Vanguard Portfolio Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Vanguard Portfolio Management's PFE Position: Q3 2026 in Review
Vanguard Portfolio Management increased its Pfizer (PFE) stake by 1% in Q3 2026, buying an estimated $33M and bringing the position to 120,474,634 shares worth $3.44B. The position accounts for 0.16% of the portfolio, ranked #107.
Vanguard Portfolio Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Vanguard Portfolio Management held 120,474,634 shares of Pfizer worth $3.44B as of Q3 2026.
- Vanguard Portfolio Management bought 1,239,604 Pfizer shares in Q3 2026, an estimated $33M.
- Pfizer made up 0.16% of Vanguard Portfolio Management's portfolio in Q3 2026, its #107 holding.
- Vanguard Portfolio Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.